Stephen L Nishimura Selected Research

integrin alphavbeta8

2/2010	Reduced expression of integrin alphavbeta8 is associated with brain arteriovenous malformation pathogenesis.
8/2006	Activation of transforming growth factor-beta by the integrin alphavbeta8 delays epithelial wound closure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen L Nishimura Research Topics

Disease

11	Chronic Obstructive Pulmonary Disease (COPD) 01/2019 - 11/2007
8	Neoplasms (Cancer) 01/2021 - 12/2005
7	Fibrosis (Cirrhosis) 01/2022 - 07/2011
4	Infections 01/2018 - 12/2009
4	Inflammation (Inflammations) 01/2017 - 08/2006
3	Mesothelioma 11/2008 - 12/2005
2	Pulmonary Edema 01/2018 - 09/2017
2	Acute Lung Injury 01/2018 - 09/2017
2	Hemorrhage 12/2016 - 06/2005
2	Arteriovenous Malformations (Arteriovenous Malformation) 08/2010 - 02/2010
1	Atherosclerosis 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Vascular Diseases (Vascular Disease) 01/2021
1	Rheumatoid Arthritis 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2018
1	Bacterial Pneumonia 01/2018
1	Persistent Infection 11/2017
1	Lung Injury 09/2017
1	Airway Remodeling 06/2014
1	Central Nervous System Vascular Malformations (Dural Arteriovenous Fistula) 10/2011
1	Lung Diseases (Lung Disease) 07/2011
1	Malignant Mesothelioma 11/2008
1	Wounds and Injuries (Trauma) 08/2006
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 06/2005
1	Perinatal Death 06/2005

Drug/Important Bio-Agent (IBA)

8	IntegrinsIBA 01/2021 - 08/2006
6	SmokeIBA 01/2019 - 02/2014
4	CollagenIBA 01/2022 - 12/2005
4	ChemokinesIBA 01/2019 - 07/2011
4	AntibodiesIBA 10/2018 - 08/2006
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 08/2006
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2015
3	Sirolimus (Rapamycin)FDA Link 01/2019 - 12/2005
2	CalciumIBA 01/2022 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 01/2015
2	LigandsIBA 01/2019 - 08/2015
2	CytokinesIBA 09/2017 - 10/2011
2	integrin beta8IBA 08/2010 - 06/2005
2	integrin alphavbeta8IBA 02/2010 - 08/2006
2	Integrin alphaVIBA 12/2009 - 11/2007
2	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 11/2008 - 12/2005
2	Transforming Growth Factor beta (TGF-beta)IBA 11/2007 - 08/2006
1	Calcium Channels (Calcium Channel)IBA 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	Connexin 43 (Connexin43)IBA 01/2022
1	Purinergic P2 Receptors (ADP Receptor)IBA 01/2022
1	Interferon Type IIBA 01/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2019
1	GalactosidasesIBA 01/2019
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2019
1	InterleukinsIBA 01/2019
1	LipopolysaccharidesIBA 01/2019
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2019
1	8-Hydroxy-2'-DeoxyguanosineIBA 01/2019
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2019
1	TensinsIBA 01/2019
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	PTEN-induced putative kinaseIBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	pirfenidoneIBA 01/2019
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2019
1	AntigensIBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 09/2017
1	EndotoxinsIBA 09/2017
1	Interleukin-6 (Interleukin 6)IBA 09/2017
1	Interleukin-17 (Interleukin 17)IBA 01/2017
1	Interleukin-17 ReceptorsIBA 01/2017
1	Protein Isoforms (Isoforms)IBA 01/2017
1	ferric ferrocyanide (Prussian blue)FDA Link 12/2016
1	Capsules (Microcapsules)IBA 01/2016
1	Chemokine ReceptorsIBA 04/2015
1	Histone Deacetylases (Histone Deacetylase)IBA 02/2014
1	Insulin-Like PeptidesIBA 02/2014
1	Insulin (Novolin)FDA Link 07/2011
1	Peptides (Polypeptides)IBA 12/2009
1	VitronectinIBA 12/2009
1	Fibronectins (Fibronectin)IBA 12/2009
1	MTOR InhibitorsIBA 11/2008
1	Gemcitabine FDA Link 11/2008
1	Keratins (Keratin)IBA 11/2008
1	Small Interfering RNA (siRNA)IBA 11/2008
1	Caspase 3 (Caspase-3)IBA 11/2008
1	Single-Chain AntibodiesIBA 03/2008
1	Surface Antigens (Surface Antigen)IBA 03/2008
1	Neoplasm Antigens (Tumor Antigens)IBA 03/2008
1	Coloring Agents (Dyes)IBA 03/2008
1	Pharmaceutical PreparationsIBA 03/2008
1	Topotecan (Hycamtin)FDA LinkGeneric 03/2008
1	Blocking AntibodiesIBA 08/2006
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 08/2006
1	Transforming Growth Factor beta2IBA 08/2006
1	TNF-Related Apoptosis-Inducing LigandIBA 12/2005
1	Death Domain ReceptorsIBA 12/2005
1	Cycloheximide (Cicloheximide)IBA 12/2005

Therapy/Procedure

4	Therapeutics 03/2014 - 12/2005